CDK12 inhibition upregulates ATG7 triggering autophagy via AKT/FOXO3 pathway and enhances anti-PD-1 efficacy in colorectal cancer
As the world’s fourth most deadly cancer, colorectal cancer (CRC) still needed the novel therapeutic drugs and target urgently. Although cyclin-dependent kinase 12 (CDK12) has been shown to be implicated in the malignancy of several types of cancer, its functional role and mechanism in CRC remain la...
Main Authors: | Zimei Wu, Wenxin Zhang, Lu Chen, Tianxiao Wang, Xinhai Wang, Huanying Shi, Liudi Zhang, Mingkang Zhong, Xiaojin Shi, Xiang Mao, Haifei Chen, Qunyi Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-03-01
|
Series: | Pharmacological Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1043661824000410 |
Similar Items
-
Inhibition of Mitochondrial Antioxidant Defense and CDK4/6 in Mesothelioma
by: Marian Kratzke, et al.
Published: (2023-05-01) -
CDK4, CDK6/cyclin-D1 Complex Inhibition and Radiotherapy for Cancer Control: A Role for Autophagy
by: Valerio Nardone, et al.
Published: (2021-08-01) -
Inhibition of autophagy-related protein 7 enhances anti-tumor immune response and improves efficacy of immune checkpoint blockade in microsatellite instability colorectal cancer
by: Wenxin Zhang, et al.
Published: (2024-04-01) -
Binding selectivity-dependent molecular mechanism of inhibitors towards CDK2 and CDK6 investigated by multiple short molecular dynamics and free energy landscapes
by: Lifei Wang, et al.
Published: (2023-12-01) -
ESRRG-PKM2 axis reprograms metabolism to suppress esophageal squamous carcinoma progression and enhance anti-PD-1 therapy efficacy
by: Tianxiao Wang, et al.
Published: (2023-09-01)